Genic Co., Ltd. (KOSDAQ:123330)

Market Cap	180.36B -10.7%
Revenue (ttm)	89.73B +46.2%
Net Income	18.85B +61.0%
EPS	2,408.73 +55.3%
Shares Out	7.82M
PE Ratio	9.57
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	108,600
Open	22,550
Previous Close	22,550
Day's Range	22,300 - 23,950
52-Week Range	15,570 - 44,100
Beta	0.60
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Genic

Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; and shampoo and tonic. It offers its products under the CELEDERMA, CELEDERMA daily, and Excuse my Frank brands. Genic Co., Ltd. was founded in 2001 and ...

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2001
• Employees: 324
• Stock Exchange: KOSDAQ
• Ticker Symbol: 123330

Financial Performance

In 2025, Genic's revenue was 78.20 billion, an increase of 56.68% compared to the previous year's 49.91 billion. Earnings were 18.89 billion, an increase of 149.73%.